Investing Profile

Alaa Halawa(1)

InvestorVC
Investor at Vir Biotechnology, Inc.
mubadala.comLos Altos, California

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NewCo Network
1599 CONNECTIONS
Self-Employed Network
495 CONNECTIONS
Cornell University Network
255 CONNECTIONS
cb
$10K - $5.0M
$100K
20
CompanyStageDateRound SizeTotal Raised
Ollin Biosciences
Series BJun 2026$330M
Series ASep 2025$100M
$430M
Co-investors: Paul Berns (ARCH Venture Partners)
Alloy Therapeutics
Series EApr 2026$40M
Series DOct 2022$42M
Series CApr 2021$75M
$170M
Co-investors: Alex Kolicich (8VC), Peter Thiel (Founders Fund), Paul Grossinger (Quvy.com), Fabian Hansen (Presight Capital)
Salma Health
Series AFeb 2026$80M
$80M
Co-investors: Paul Berns (ARCH Venture Partners)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: David Schenkein (GV (Google Ventures)), Hemant Taneja (General Catalyst), Elena Viboch (General Catalyst), Ramnik Arora (FTX Ventures), Max Rimpel (Index Ventures), Niko Bonatsos (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners), Jay Markowitz (ARCH Venture Partners), Justin Kao (DFJ Growth), Eoghan McCabe (Spark-Local, Inc), Jared Friedman (Israel Defense Forces), Scott Belsky (capitalB), Balaji Srinivasan, Arash Ferdowsi, Karim Atiyeh
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Kristina Burow (ARCH Venture Partners), Paul Berns (ARCH Venture Partners)
GC Therapeutics
Series ASep 2024$65M
$65M
Co-investors: Vineeta Agarwala (Andreessen Horowitz)
Centenara Labs
Series BSep 2023$75M
$75M
EpiBiologics
Series AMar 2023$73M
$200M
Co-investors: David Schenkein (GV (Google Ventures)), Anika Gupta (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures), Gaurav Aggarwal (Vivo Capital), Nisa Leung (Qiming Venture Partners), Laura Brass (MPM BioImpact)
Board Member Neumora2021 - Present
Board Member xilis2021 - Present
Founding Investor and Board Member Pretzel Therapeutics2021 - Present
Board Member Alloy Therapeutics, Inc.2021 - Present
Board Observer Outpace Bio2021 - Present
Board Observer EQRx2021 - Present
Investor Science 372020 - Present
Investor Ciitizen2020 - Present
Investor Lyell Immunopharma2020 - Present
Board Member Wellpay2020 - Present
Board Member Innovaccer2019 - Present
Board Observer IonQ Inc.2019 - Present
Investor Vividion Therapeutics. Inc.2019 - Present
Board Observer Unlearn.AI2019 - Present
Investor Primer AI2018 - Present
Investor Orca Biosystems Inc.2018 - Present
Investor Vir Biotechnology, Inc.2018 - Present
Investor insitro2018 - Present
Board Observer Recursion Pharmaceuticals2017 - Present
Head of Healthcare Mubadala2017 - Present
Vice President - Mubadala Technology MubadalaPresent
Founding Investor MetseraPresent
Founding Investor and Board Member Ollin BiosciencesPresent
Founding Investor and Board Member Tenvie TherapeuticsPresent
Cofounder and Chief Executive Officer Salma HealthPresent
Investor Orca BioPresent
Investor Vividion Therapeutics, Inc.Present
Board Observer IonQPresent
Board Observer Self-EmployedPresent
Board Observer RecursionPresent
Investor Primer.aiPresent
Investor InsitroPresent
Board Observer Unlearn.aiPresent
Board Member WellPayPresent
Board Member XilisPresent
Executive Director / Head of US Ventures MubadalaPresent
Board Observer NewCoPresent
Director, Strategy & Corporate Development GLOBALFOUNDRIES2014 - 2015
Vice President - Mubadala Technology Mubadala Development Company2009 - 2014
Director of Marketing and Product Management Globitel2004 - 2009
Cornell University Master of Business Administration (MBA) Business Administration and Management, General
University of Jordan B.Sc. Electrical Engineering